Directors Deals 

Dechra directors' financial plans

Dechra directors' financial plans

Shareholders in Dechra Pharmaceuticals (DPH) were the beneficiaries of a 24 per cent hike in the annual dividend, but it’s clear that the veterinary products group will also be looking to attract potential investors through an intensified focus on margins.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now